about
Role of adult hippocampal neurogenesis in stress resilienceA review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of actionNorepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitorsGABAB(1) receptor subunit isoforms differentially regulate stress resilienceThe antidepressant fluoxetine restores plasticity in the adult visual cortex.Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosisTowards translational rodent models of depression.Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man.Faster, better, stronger: towards new antidepressant therapeutic strategies.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis.When ageing meets the blues: Are current antidepressants effective in depressed aged patients?Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions.Increased sensitivity to the effects of chronic social defeat stress in an innately anxious mouse strain.Elucidation of the neural circuits activated by a GABAB receptor positive modulator: Relevance to anxiety.Early-life stress induces visceral hypersensitivity in mice.Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice.Neuroscience. A glutamate pathway to faster-acting antidepressants?Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action.Hippocampal group III mGlu receptor mRNA levels are not altered in specific mouse models of stress, depression and antidepressant action.Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling.Microbial regulation of hippocampal miRNA expression: Implications for transcription of kynurenine pathway enzymes.Adult Hippocampal Neurogenesis Is Regulated by the Microbiome.The nuclear receptor Tlx regulates motor, cognitive and anxiety-related behaviours during adolescence and adulthood.Differential roles of GABAB1 subunit isoforms on locomotor responses to acute and repeated administration of cocaine.Deletion of TLX and social isolation impairs exercise-induced neurogenesis in the adolescent hippocampus.GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice.Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice.Automated tests for measuring the effects of antidepressants in mice.Programming Bugs: Microbiota and the Developmental Origins of Brain Health and DiseaseEnduring effects of muscarinic receptor activation on adult hippocampal neurogenesis, microRNA expression and behaviour
P50
Q28081420-1D0023E0-F01E-4014-8547-264DAEFEE07CQ28305159-73F48327-583B-4F77-A4F3-E4104BA287A2Q34321467-6E71E857-0FC5-4804-87F8-F5AFC3E29B6EQ34408846-AFC7089B-302A-4F35-A410-53B7F48FB41CQ34771195-203A32DA-1ED0-4B90-8506-A7023E000994Q35894597-A11CCDC6-CC68-42B4-9C70-CFC3679E3AA2Q38092709-558E5AB4-B13F-451E-98BC-07FEE2847DF1Q38155704-46D5D4C1-7E03-4EDE-8F30-0390F6060E33Q38236977-0CEC0965-99A0-4B63-AE1E-78A2A38A002AQ38266162-BA6CE717-C31B-4D90-9416-472E4F41E21FQ38279262-F1C80C4E-637B-4B33-9FA1-C087B27D606DQ38520933-48A6CEA1-0451-46EA-8A94-74770F61C84AQ38724866-D541C8A6-D950-465B-B416-0DD126728B35Q39288170-91C4D7F8-9461-42A1-AB99-E1280174F420Q39452195-F95B50DA-15F2-4B21-8337-BCC7BCA94015Q39653553-8AEBBCE3-5388-42D8-823A-7F1738560041Q40233997-FD79401D-CE4E-45A9-9B79-46F9EEF643F5Q42931853-723A1559-AD76-4125-8702-2A2272ED40D7Q44122550-EF261D22-3080-4D1E-9540-986C357EA199Q44353422-46461A54-E2CF-4D99-A407-FBDAFF6CC782Q44459220-DC23AE89-AEAC-42E3-B9F3-475E0D0BD366Q46269465-E9DD7C06-9B71-4C87-9711-A6C7097D66A4Q46331922-2F507ACC-5820-4225-AD38-5CA43829D1BAQ46769891-8672E862-5BE4-4EF8-BB34-F59DE4AA79E7Q47443382-C4E4B5D7-2386-4B7E-AFE1-AD4BFC1CDD11Q47632975-527E992D-40CB-4A16-82C6-9C18CC4D74B9Q47668656-48DCB1FD-63E2-4925-8F9C-983354DA2033Q47990854-BD6FA55C-927F-4725-8064-6872C3314169Q48264381-BDFF1609-4F3C-4848-BAD3-CBDA5823E262Q48393834-AD3DA82E-0D2E-451A-834C-8A50BADD9141Q48414511-6CF5FD11-9E17-462C-A07E-6E9A12D667B3Q48820635-428374D2-954A-4266-967F-FF97CC4F46FDQ48963867-4D2CF352-0082-4136-85AC-4EB3572F0CD4Q90669203-9C5887FF-F1C8-452B-8DBF-6F9195DDD035Q91076336-27223FB2-2753-4429-867C-2B970E024CC6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Olivia F O'Leary
@ast
Olivia F O'Leary
@en
Olivia F O'Leary
@es
Olivia F O'Leary
@nl
Olivia F O'Leary
@sl
type
label
Olivia F O'Leary
@ast
Olivia F O'Leary
@en
Olivia F O'Leary
@es
Olivia F O'Leary
@nl
Olivia F O'Leary
@sl
altLabel
Olivia O'Leary
@en
prefLabel
Olivia F O'Leary
@ast
Olivia F O'Leary
@en
Olivia F O'Leary
@es
Olivia F O'Leary
@nl
Olivia F O'Leary
@sl
P106
P1153
16302140700
P21
P31
P496
0000-0002-9171-2032